Clinical trial
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
NCT00728481 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- December 31, 2010
- Enrollment
- 51 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ee, eosinophilic esophagitis, gastroesophageal reflux disease, gerd